Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699616 | Clinical Oncology | 2008 | 5 Pages |
Abstract
This prospective randomised controlled study of 40 patients could not show a statistically significant advantage with 6 months of pentoxifylline compared with standard measures for late radiation-induced rectal bleeding. However, a modest benefit cannot be excluded and larger randomised placebo-controlled trials with longer durations of pentoxifylline treatment may be justified.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R. Venkitaraman, J. Coffey, A.R. Norman, F.V. James, R.A. Huddart, A. Horwich, D.P. Dearnaley,